Abstract
BackgroundSeasonal vaccination with the RTS,S/AS01Emalaria vaccine given alongside seasonal malaria chemoprevention (SMC) substantially reduces malaria in young children. The WHO has recommended the use of RTS,S/AS01E, including seasonal vaccination, in areas with seasonal malaria transmission. This study aimed to identify potential strategies to deliver RTS,S/AS01E, and assess the considerations and recommendations for delivery of seasonal malaria vaccination in Mali, a country with highly seasonal malaria.MethodsPotential delivery strategies for RTS,S/AS01Ein areas with seasonal malaria were identified through a series of high level discussions with the RTS,S/AS01Eplus SMC trial investigators, international and national immunisation and malaria experts, and through the development of a theory of change. These were explored through qualitative in-depth interviews with 108 participants, including national-level, regional-level and district-level malaria and immunisation programme managers, health workers, caregivers of children under 5 years of age, and community stakeholders. A national-level workshop was held to confirm the qualitative findings and work towards consensus on an appropriate strategy.ResultsFour delivery strategies were identified: age-based vaccination delivered via the Essential Programme on Immunisation (EPI); seasonal vaccination via EPI mass vaccination campaigns (MVCs); a combination of age-based priming vaccination doses delivered via the EPI clinics and seasonal booster doses delivered via MVCs; and a combination of age-based priming vaccination doses and seasonal booster doses, all delivered via the EPI clinics, which was the preferred strategy for delivery of RTS,S/AS01Ein Mali identified during the national workshop. Participants recommended that supportive interventions, including communications and mobilisation, would be needed for this strategy to achieve required coverage.ConclusionsFour delivery strategies were identified for administration of RTS,S/AS01Ealongside SMC in countries with seasonal malaria transmission. Components of these delivery strategies were defined as the vaccination schedule, and the delivery system(s) plus the supportive interventions needed for the strategies to be effective. Further implementation research and evaluation is needed to explore how, where, when and what effective coverage is achievable via these new strategies and their supportive interventions.
Funder
UK Joint Global Health Trials
PATH MVI
Subject
Public Health, Environmental and Occupational Health,Health Policy
Reference33 articles.
1. Effectiveness of seasonal malaria chemoprevention at scale in west and central Africa: an observational study
2. World Health Organization . World malaria report 2022. Geneva, 2022.
3. Effect of Adding Azithromycin to Seasonal Malaria Chemoprevention
4. World Health Organization . Full evidence report on the RTS,S/AS01 malaria vaccine. 2021.
5. World Health Organization . Malaria: the malaria vaccine implementation programme (MVIP). 2020. Available: https://www.who.int/news-room/questions-and-answers/item/malaria-vaccine-implementation-programme